Chemical Stock Targets 25% Annual Growth: Can Its Pharma Acquisition and Rs17,496 Cr Pipeline Drive Expansion?
India, Nov. 22 -- The Indian specialty chemicals market is seeing a trend of moving towards high-value goods, including pharmaceutical intermediates and advanced materials, thereby providing room for those players that have a customer-centric approach and have the capacity to manufacture a diverse range of products.
The purchase of a majority stake in Bliss GVS Pharma has been a milestone in Anupam Rasayan's endeavor to diversify its portfolio to include pharmaceutical formulations. Along with becoming more profitable in Q2 FY27, it can take advantage of the newly acquired contracts and synergies through its acquisitions.
With a market capitalisation of Rs. 15,079 cr, the shares of Anupam Rasayan India Ltd closed at Rs. 1324.50 per sha...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.